openPR Logo
Press release

Hemostasis Products Market to Cross US$ 7 Billion by 2024

11-23-2016 08:25 AM CET | Health & Medicine

Press release from: Market Research Engine Reports

Hemostasis Products Market

Hemostasis Products Market

New York, November 22: Market Research Engine has published a new report titled as “Hemostasis Products Market By Product (Advanced Hemostasis, Infusible Hemostasis, Topical Hemostasis), By Application (Thrombosis, Stroke, Trauma, Surgery, Hemophilia, Myocardial Infarction) and by End Users (Clinics & Hospitals) - Global Industry Analysis and Forecast 2016 - 2024”

How Big is the Global Hemostasis Products Market?

The Hemostasis products market is expected to exceed more than US$ 7 Billion by 2024; Growing at a CAGR of more than 4% in the given forecast period.

Download Free Sample Report: http://www.marketresearchengine.com/requestsample/hemostasis-products-market-report

The market for Hemostasis products has generously profited in the previous couple of years. Inferable from the inconceivable innovative work exercises attempted in the field of Hemostasis innovation, empowering the advancement of very solid Hemostasis items for use in crisis circumstances. Broad research exercises in the field have additionally brought about the advancement of a wide number of imaginative items, which are as a rule emphatically got by national and worldwide endorsement offices.

The major driving factors of Hemostasis products market are as follows:

Rise in many surgical and trauma cases
Extensive research and technological advancements

The restraining factors of Hemostasis products market are as follows:

Rising use of off label product and patent loss
Strict regulatory policies

The hemostasis products market is segmented on the lines of its product, application, end user and regional analysis. Product segmentation is further classified into advanced hemostasis, infusible hemostasis and topical hemostasis. Hemostasis segmentation covers Synthetic Sealants, Fibrin, Thrombin and Flowable. Infusible hemostasis segmentation covers prothrombin complex, fresh frozen plasma, FVIII derived from blood and platelet concentrates from donor blood. Topical segmentation covers collagen, oxidized regenerated cellulose, polysaccharide and gelatin.

Under application segmentation it covers thrombosis, stroke, myocardial infarction, hemophilia, surgery and trauma. Based on end user it covers clinics and hospitals. The hemostasis products market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Browse Full Report: http://www.marketresearchengine.com/reportdetails/hemostasis-products-market-report

This report provides:

1) An overview of the global market for hemostasis products and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2024.

3) Identifications of new market opportunities and targeted promotional plans for hemostasis products.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for The Hemostasis Products Market for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Baxter International, Inc., C. R. Bard, Inc., CSL Behring LLC, Grifols, S.A., HemCon Medical Technologies, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, and Pfizer, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Hemostasis Products Market has been segmented as below:

By Product Segment Analysis

• Advanced Hemostasis
Synthetic sealants
Fibrin
Thrombin
Flowable

• Infusible Hemostasis
Prothrombin complex
Fresh frozen plasma
FVIII derived from blood
Platelet concentrates from donor blood

• Topical Hemostasis
Collagen
Oxidized regenerated cellulose
Polysaccharide
Gelatin

By Application Analysis

Thrombosis
Stroke
Myocardial infarction
Hemophilia
Surgery
Trauma

By End User Analysis

Clinics
Hospitals

By Regional Analysis

North America
Europe
Asia-Pacific
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all hemostasis products.

2) Identify growth segments and opportunities in the industry.

3) Facilitate decision making on the basis of strong historic and forecast of hemostasis products data.

4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: http://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemostasis Products Market to Cross US$ 7 Billion by 2024 here

News-ID: 385770 • Views:

More Releases from Market Research Engine Reports

Bio-implants Market is Expected to Cross US$ 134 Billion by 2022
The Global Bio-implants Market is segmented on the lines of its application, origin, material and regional. Based on application segmentation it covers ophthalmic and neurostimulators implants, dental, orthopedics and trauma implants, spinal implants and cardiovascular implants. Cardiovascular implants are further segmented into pacing devices and stents. Browse Full Report: https://www.marketresearchengine.com/reportdetails/bio-implants-market-report How Big is the Global Bio-Implants Market? The Global Bio-implants Market is expected to exceed more than US$ 134 billion by 2017 in
Cardiac Monitoring Advanced Technologies Market to Reach US$ 29 Billion Globally …
The Cardiac Monitoring Advanced Technologies Market is segmented on the lines of its product, application and regional. Based on cardiac monitoring product segmentation it covers cardiac output monitoring (COM) devices, implantable loop recorders (ILR), event monitors and electrocardiogram (ECG) devices. Under cardiac rhythm management product segmentation it covers cardiac resynchronization therapy (CRT) devices, pacemakers and defibrillators. The cardiac monitoring advanced technologies market is segmented on the lines of its application
Vascular Access Devices Market is Expected to Reach US$ 8.0 Billion by Globally …
The vascular access devices market is segmented on the lines of its product type, application, route of insertion, end user and regional. Product type is further segmented into accessories, central and peripheral. Central type consists of implantable ports, dialysis catheters, CVC and PLCC. Peripheral type contains midline catheters and PIV catheters. Based on application segmentation it cover diagnostic testing, transfusion of blood products, administration of fluid and nutrition and medication
Testing, Inspection and Certification (T.I.C.) Market is Expected to Cross US$ 2 …
The testing, inspection and certification market is segmented on the lines of its application and regional. Based on application segmentation the testing, inspection and certification market covers textile, automation, automotive, food and beverage, aerospace, oil and gas and others. Browse Full Report @: https://www.marketresearchengine.com/reportdetails/testing-inspection-and-certification-tic-market How Big is the Testing, Inspection and Certification (T.I.C.) Market? The Testing, Inspection and Certification market is expected to exceed more than US$ 285 Billion by 2024; Growing

All 4 Releases


More Releases for Hemostasis

Hemostasis Diagnostics Market Forecast Overview, 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Hemostasis Diagnostic Devices And Equipment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $9.85 billion
Hemostasis Valves Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Hemostasis Valves Market Size Projected to Reach USD 255 Billion by 2030, Growing at 5.80% CAGR Ameco Research is proud to announce the launch of its latest market research report, Hemostasis Valves Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Hemostasis Diagnostics Market: Global Industry Analysis 2024
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has
Hemostasis Diagnostics Market: Global Markets & Advanced Technologies
Hemostasis, the body’s normal physiological response to stop bleeding after a vascular injury, is a key procedure in the first line of action attempted post an injury, by the body itself or by medical respondents. Preventing significant loss of blood is vital for the survival of a patient, making hemostasis the focus of widespread research and study. Owing to the critical nature of the procedure, the hemostasis products market has
Hemostasis Products Market: Applications and Global Markets
This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study
Predictions for 2024: Hemostasis Products Market
The top four vendors operating in the global hemostasis products market, including Ethicon, Pfizer Inc., Baxter International, Inc., and CR Bard, Inc., accounted for a share of nearly 41% in the market in 2015, states Transparency Market Research in a recent report. In the seemingly fragmented market, where small- and medium-scale vendors accounted for over 59% in the overall market in the 2015, a large number of these players provided